7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $88M | -$35M | 0.0% | -31.5% | -$24M | $50M | $19M |
| 2024 | $71M | -$43M | 0.0% | -48.4% | -$52M | $40M | $26M |
| 2023 | $49M | -$52M | 0.0% | -84.2% | -$46M | $40M | $26M |
| 2022 | $38M | -$65M | 0.0% | -132.4% | -$48M | $30M | $43M |
| 2021 | $55M | -$43M | 0.0% | -75.1% | -$30M | $10M | $33M |
| 2020 | $46M | -$65M | 0.0% | -50.3% | -$23M | $28M | $62M |
| 2019 | $25M | -$31M | 0.0% | -108.9% | -$23M | — | $5M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $26M | -$8M | 0.0% | -24.3% | -$10M | $50M | $26M |
| Dec '25 | $29M | -$4M | 0.0% | -6.8% | $692000 | $50M | $19M |
| Sep '25 | $22M | -$9M | 0.0% | -32.4% | -$9M | $50M | $17M |
| Jun '25 | $20M | -$11M | 0.0% | -48.6% | -$7M | $50M | $21M |
| Mar '25 | $18M | -$11M | 0.0% | -50.9% | -$9M | $40M | $18M |
| Dec '24 | $20M | -$8M | 0.0% | -32.5% | -$5M | $40M | $26M |
| Sep '24 | $18M | -$10M | 0.0% | -47.3% | -$11M | $40M | $31M |
| Jun '24 | $18M | -$11M | 0.0% | -46.0% | -$20M | $40M | $42M |
| Mar '24 | $15M | -$14M | 0.0% | -74.4% | -$16M | $40M | $11M |
| Dec '23 | $15M | -$9M | 0.0% | -46.8% | -$15M | $40M | $26M |
| Sep '23 | $13M | -$11M | 0.0% | -53.2% | -$10M | $30M | $20M |
| Jun '23 | $12M | -$13M | 0.0% | -92.0% | -$5M | $30M | $17M |
| Mar '23 | $9M | -$19M | 0.0% | -180.8% | -$15M | $30M | $25M |
| Dec '22 | $10M | -$20M | 0.0% | -144.6% | -$14M | $30M | $43M |
| Sep '22 | $11M | -$14M | 0.0% | -95.5% | -$11M | $22M | $15M |
| Jun '22 | $11M | -$16M | 0.0% | -106.2% | -$10M | $23M | $24M |
| Mar '22 | $7M | -$16M | 0.0% | -220.8% | -$13M | $10M | $16M |
| Dec '21 | $7M | -$13M | 0.0% | -161.7% | -$11M | $10M | $33M |
| Sep '21 | $7M | -$12M | 0.0% | -200.4% | -$9M | $30M | $48M |
| Jun '21 | $12M | -$11M | 0.0% | -89.1% | $809000 | $33M | $56M |
How the market has priced BDSX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, BIODESIX INC's revenue has grown 14.2% per year. These are computed facts, not advice.
As of FY2025, BIODESIX INC reported $50M of total debt against $19M of cash; operating income covered interest expense -3.6×.
In FY2025, gross margin was —, operating margin -31.5%, and net margin -39.9%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.